Research programme: Haemophilus influenzae type b vaccine - BioNet-Asia

Drug Profile

Research programme: Haemophilus influenzae type b vaccine - BioNet-Asia

Latest Information Update: 01 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioNet-Asia
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Haemophilus infections

Most Recent Events

  • 01 Dec 2017 Discontinued for Haemophilus infections in Thailand (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for research development in Haemophilus-infections in Thailand (Parenteral, Injection)
  • 01 Oct 2012 Early research in Haemophilus infections in Thailand (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top